We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

77 ELEKTRONIKA

Develops, manufactures, and markets fully automated and semi-automated urine analyzers, blood glucose meters, rapid t... read more Featured Products: More products

Download Mobile App





77 Elektronika Showcases Latest Developments in Urinalysis

By LabMedica International staff writers
Posted on 08 Feb 2024
Print article
Image: The new pediatric measurement mode of LabUMat 2 and UriSed 3 PRO demonstrated at Medlab Middle East 2024 (Photo courtesy of 77 Elektronika)
Image: The new pediatric measurement mode of LabUMat 2 and UriSed 3 PRO demonstrated at Medlab Middle East 2024 (Photo courtesy of 77 Elektronika)

At Medlab Middle East 2024, 77 Elektronika (Budapest, Hungary) is demonstrating how its high-end urinalysis products can boost laboratory efficiency.

77 Elektronika is showcasing its full product range, including its latest developments in urinalysis, such as the new pediatric measurement mode of LabUMat 2 and UriSed 3 PRO or the brand new research use only (RUO) feature of the UriSed mini device. Urine sediment analysis is very sensitive to inhomogeneous particle distribution in the sample: some urine sediment particles subside quickly and hence, proper mixing is crucial to obtain reliable results. 77 Elektronika has implemented sample level adaptive mixing procedure into its fully automated UriSed technology instruments, the UriSed 2 and UriSed 3 PRO. During sample mixing some urine is aspirated from the test tube and pushed back again. This “sip and spit” mixing is repeated to make sure that all particles are homogenized. This standardized method provides consistent results quickly and effectively.

Visitors to the 77 Elektronika booth at Medlab Middle East 2024 can experience UriSed Technology which offers a premium category solution for sediment analysis, providing high-resolution whole-view field microscopic images in an automatic and reproducible way. The goal of UriSed Technology is to make urinary sediment analysis faster, more reliable, and more operator-independent, eliminating the need for manual microscopy while adhering to gold standard guidelines. With UriSed technology, laboratories can achieve accurate and dependable results in just a fraction of the time it takes with traditional methods. The technology provides a detailed analysis of urine samples, detecting red and white blood cells, epithelial cells, bacteria, and other microscopic elements. This makes it an essential tool for diagnosing various medical conditions, including urinary tract infections, kidney diseases, and many more. The fully automated UriSed 3 PRO urine sediment analyzer provides automatic and reproducible results, ensuring that each sample is analyzed with the same precision and accuracy. Also on display at the event is the UriSed mini device which now comes with the brand new feature of Body Fluid Measurement mode which is available only for RUO mode and not for diagnostic purposes. The two measurement phases of stained and unstained samples enable a wider range of sample analysis that includes various body fluid types.

Related Links:
77 Elektronika

New
Gold Member
Strep Pneumoniae Rapid Test
Strep Pneumoniae (6503 – 6573)
Gold Member
Hematology Analyzer
Swelab Lumi
New
Myocardial Infarction Test
Savvycheck SensA Heart
New
Chagas Disease Test
Simple/Stick Chagas/WB

Print article

Channels

Molecular Diagnostics

view channel
Image: The kit includes a container with a film, a compact optical device for attaching a smartphone, and a diagnostic app (Photo courtesy of KIST)

Urine-Based Bladder Cancer Diagnostic Kit to Reduce Need for Unnecessary Cystoscopies

Bladder cancer has a high cure rate of over 90% when detected early, but it is characterized by a recurrence rate of 70%, which requires continuous monitoring. Late-stage detection often results in major... Read more

Microbiology

view channel
Image: The QIAstat-Dx mini gastrointestinal panel has secured U.S. clearance to support year-round outpatient care (Photo courtesy of QIAGEN)

Syndromic Panel Provides Fast Answers for Outpatient Diagnosis of Gastrointestinal Conditions

Acute infectious gastroenteritis is a major cause of outpatient visits and hospitalizations in the U.S., with over 179 million cases estimated annually. Now, a new gastrointestinal panel designed to provide... Read more

Pathology

view channel
Image: The AI tool can search through data and histology images for much more precise information on cancer treatment effectiveness (Photo courtesy of Shutterstock)

AI Tool Analyzes 30K Data Points Per Medical Imaging Pixel in Cancer Search

A new artificial intelligence (AI)-powered tool can detect cell-level characteristics of cancer by analyzing data from very small tissue samples, some as tiny as 400 square micrometers, equivalent to the... Read more

Technology

view channel
Image: Human tear film protein sampling methods (Photo courtesy of Clinical Proteomics. 2024 Mar 13;21:23. doi: 10.1186/s12014-024-09475-8)

New Lens Method Analyzes Tears for Early Disease Detection

Bodily fluids, including tears and saliva, carry proteins that are released from different parts of the body. The presence of specific proteins in these biofluids can be a sign of health issues.... Read more

Industry

view channel
Image: The game-changing immunoassay diagnostics platform delivers results from whole blood sample in 10 minutes (Photo courtesy of SpinChip)

bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics

bioMérieux (Marcy l’Étoile, France) has agreed to acquire SpinChip Diagnostics (Oslo, Norway), the developer of a game-changing immunoassay diagnostics platform. The small benchtop analyzer is well adapted... Read more
MEDLAB 2024
Copyright © 2000-2025 Globetech Media. All rights reserved.